India, Oct. 12 -- The following biotech stocks reached a 52-week high on October 9, 2026, driven by catalysts such as achieving new regulatory milestones.
Humana Inc. (HUM)
Humana functions as a consumer healthcare company, hosting the CenterWell healthcare services and providing Medicare and Medicaid through its insurance services. On Friday, the company touched a 52-week high of $456.50 following a significant 11% rise in the intraday trade. Humana reported an improved Star Rating from the Centers for Medicare and Medicaid Services (CMS) as about 95% of the company's Medicare Advantage members were enrolled in 4-star plans or more. Compared to the previous year, the company met 663,000 more care opportunities as 534,000 members complete...